GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Genomic Vision SA (CHIX:GVp) » Definitions » Gross Profit

Genomic Vision (CHIX:GVP) Gross Profit : €1.38 Mil (TTM As of Jun. 2023)


View and export this data going back to 2019. Start your Free Trial

What is Genomic Vision Gross Profit?

Genomic Vision's gross profit for the six months ended in Jun. 2023 was €0.70 Mil. Genomic Vision's gross profit for the trailing twelve months (TTM) ended in Jun. 2023 was €1.38 Mil.

Gross Margin % is calculated as gross profit divided by its revenue. Genomic Vision's gross profit for the six months ended in Jun. 2023 was €0.70 Mil. Genomic Vision's Revenue for the six months ended in Jun. 2023 was €0.82 Mil. Therefore, Genomic Vision's Gross Margin % for the quarter that ended in Jun. 2023 was 85.85%.

Genomic Vision had a gross margin of 85.85% for the quarter that ended in Jun. 2023 => Durable competitive advantage

During the past 10 years, the highest Gross Margin % of Genomic Vision was 98.83%. The lowest was 41.09%. And the median was 80.20%.


Genomic Vision Gross Profit Historical Data

The historical data trend for Genomic Vision's Gross Profit can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genomic Vision Gross Profit Chart

Genomic Vision Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Gross Profit
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.58 0.92 0.70 0.81 1.27

Genomic Vision Semi-Annual Data
Dec13 Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23
Gross Profit Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.45 0.36 0.60 0.67 0.70

Competitive Comparison of Genomic Vision's Gross Profit

For the Diagnostics & Research subindustry, Genomic Vision's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Genomic Vision's Gross Profit Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Genomic Vision's Gross Profit distribution charts can be found below:

* The bar in red indicates where Genomic Vision's Gross Profit falls into.



Genomic Vision Gross Profit Calculation

Gross Profit is the different between the sale prices and the cost of buying or producing the goods.

Genomic Vision's Gross Profit for the fiscal year that ended in Dec. 2022 is calculated as

Gross Profit (A: Dec. 2022 )=Revenue - Cost of Goods Sold
=1.48 - 0.207
=1.27

Genomic Vision's Gross Profit for the quarter that ended in Jun. 2023 is calculated as

Gross Profit (Q: Jun. 2023 )=Revenue - Cost of Goods Sold
=0.82 - 0.116
=0.70

Gross Profit for the trailing twelve months (TTM) ended in Jun. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was €1.38 Mil.

Gross Profit is the numerator in the calculation of Gross Margin.

Genomic Vision's Gross Margin % for the quarter that ended in Jun. 2023 is calculated as

Gross Margin % (Q: Jun. 2023 )=Gross Profit (Q: Jun. 2023 ) / Revenue (Q: Jun. 2023 )
=(Revenue - Cost of Goods Sold) / Revenue
=0.70 / 0.82
=85.85 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Genomic Vision  (CHIX:GVp) Gross Profit Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Genomic Vision had a gross margin of 85.85% for the quarter that ended in Jun. 2023 => Durable competitive advantage


Genomic Vision Gross Profit Related Terms

Thank you for viewing the detailed overview of Genomic Vision's Gross Profit provided by GuruFocus.com. Please click on the following links to see related term pages.


Genomic Vision (CHIX:GVP) Business Description

Traded in Other Exchanges
N/A
Address
80-84 rue des Meuniers, Green Square, Batiment E, Bagneux, FRA, 92220
Genomic Vision SA is a molecular diagnostics and technology company specialized in the development of single DNA detection tools for research and in vitro diagnostics.